XML 36 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Compensation Plans (Tables)
6 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of stock inventive plan changes
            
   Number of
Class A Shares
  Weighted Average Exercise Price  Number of
Class C Shares
  Weighted Average Exercise Price
             
Outstanding at January 1, 2021   1,072,863   $4.22    662,666   $4.61 
Adjustment for effect of stock dividends   47,594         33,136      
Granted   —           —        
Exercised   (97,313)        —        
Cancelled   —           —        
Outstanding at June 30, 2021   1,023,144   $4.29    695,802   $4.61 
                     
As of June 30, 2021:                    
Options exercisable   1,023,144   $4.29    695,802   $4.61 
                     
As of June 30, 2021:                    
Available options for future grant   358,462         279,825      
                     
Weighted average contractual term of options                    
outstanding at June 30, 2021   5.18 years         6.32 years      
                     
Weighted average contractual term of options                    
exercisable at June 30, 2021   5.18 years         6.32 years      
                     
Aggregated intrinsic value of options                    
outstanding at June 30, 2021 (1)  $4,135,399        $2,585,420      
                     
Aggregated intrinsic value of options                    
exercisable at June 30, 2021 (1)  $4,135,399        $2,585,420      

 

(1) The Company used a stock price of $8.33 as of June 30, 2021 to derive intrinsic value.

 

A summary of the status of the Company’s stock compensation plans as of June 30, 2020, and the changes during the six months ended June 30, 2020, are presented below:

 

   Number of
Class A Shares
  Weighted Average Exercise Price  Number of
Class C Shares
  Weighted Average Exercise Price
             
Outstanding at January 1, 2020   1,086,053   $4.41    594,132   $5.36 
Adjustment for effect of stock dividends   29,099         22,544      
Granted   77,000         180,000      
Exercised   (78,803)        —        
Cancelled   —           —        
Outstanding at June 30, 2020   1,113,349   $4.27    796,676   $4.87 
                     
As of June 30, 2020:                    
Options exercisable   1,013,955   $4.27    561,440   $5.11 
                     
As of June 30, 2020:                    
Available options for future grant   325,372         266,500      
                     
Weighted average contractual term of options                    
outstanding at June 30, 2020   5.97 years         6.18 years      
                     
Weighted average contractual term of options                    
exercisable at June 30, 2020   5.61 years         5.32 years      
                     
Aggregated intrinsic value of options                    
outstanding at June 30, 2020 (1)  $2,568,502        $1,360,855      
                     
Aggregated intrinsic value of options                    
exercisable at June 30, 2020 (1)  $2,338,090        $823,712      

 

(1) The Company used a stock price of $6.58 as of June 30, 2020 to derive intrinsic value.